FDA Issues Draft Guidance on Developing Drugs for C. Diff. Infections

In a new draft guidance released Thursday, the FDA laid out its thinking on developing drugs that treat Clostridioides difficile infection (CDI), as well as those that prevent and reduce recurrence of the condition.
Source: Drug Industry Daily